Hormone receptor positive breast cancer

Hormone receptor-positive breast cancer is a subtype of mammary carcinoma characterized by tumor cells that express nuclear receptors for estrogen, progesterone, or both Pathophysiologically, the binding of endogenous estrogen or progesterone to these receptors triggers intracellular signaling cascades and gene transcription that drive neoplastic cellular proliferation, survival, and tumor progression Identification of this biomarker profile via immunohistochemistry establishes hormone sensitivi...

Hormone receptor-positive breast cancer is a subtype of mammary carcinoma characterized by tumor cells that express nuclear receptors for estrogen, progesterone, or both Pathophysiologically, the binding of endogenous estrogen or progesterone to these receptors triggers intracellular signaling cascades and gene transcription that drive neoplastic cellular proliferation, survival, and tumor progression

Affecting primarily women, though it also occurs rarely in men, it represents the most common molecular form of breast malignancy, comprising approximately 70% to 80% of all diagnoses

Affecting primarily women, though it also occurs rarely in men, it represents the most common molecular form of breast malignancy, comprising approximately 70% to 80% of all diagnoses

Identification of this biomarker profile via immunohistochemistry establishes hormone sensitivity, defining a disease state that is biologically dependent on steroid hormone signaling